Viewing Study NCT02502812

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:07 AM
Ignite Modification Date: 2026-02-27 @ 10:31 PM
Study NCT ID: NCT02502812
Status: COMPLETED
Last Update Posted: 2017-05-08
First Post: 2015-07-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cardiovascular Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bioequivalence View
None SB224326 View
None clopidogrel View
None Relative bioavailability View